 HOLLISTON, Mass., May 24, 2021 PRNewswire -- Biostage, Inc. OTCQB: BSTG Biostage or the Company, a bioengineering company developing next-generation esophageal implants based its novel CellframeTM and CellspanTM technology, today announced its financial results for the three months ended March 31, 2021. 